A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.
- Resource Type
- journal article
- Authors
- Freedman MS; Bar-Or A; Oger J; Traboulsee A; Patry D; Young C; Olsson T; Li D; Hartung HP; Krantz M; Ferenczi L; Verco T; MAESTRO-01 Investigators; Freedman, M S; Bar-Or, A; Oger, J; Traboulsee, A; Patry, D; Young, C; Olsson, T
- Source
- Neurology; 10/18/2011, Vol. 77 Issue 16, p1551-1560, 10p
- Subject
- Language
- ISSN
- 00283878